A short transcript excerpt from a conversation (recorded Feb 28, 2025) with Dr. Robert Whitfield discussing how elevated toxin test results (mycotoxins, heavy metals, organic acids) influence decisions about fat transfer procedures and the role of patient informed consent; also touching briefly on breast implants and surgical placement considerations.
Someone has an extremely poor toxicity test, meaning they have a ton of mycotoxins like aflatoxin or fumescens or something like that, plus maybe heavy metals or isobutyric acid or all these different chemical exposures. I just tell them, we're not going to do your fat transfer. You're going to have to go through our detox program and then repeat that test to make sure that you're in the best possible position. Now, if someone comes to me and says, hey, Dr. Whitfield, I know I don't have a great talks test, I understand that, I accept that, but I still want to do a fat transfer, well, that's somebody then making an informed decision. So yes, you can say those folks are, would put themselves at a different, you know, risk stratification. But that's having understood all the information at that point, I definitely want to.
Get into ways of, of supporting the body's detox pathways. I think that's a really important conversation to have. But for women that are, you know, I mean, many women get, get breast implants and, and, and they enjoy them, their partners enjoy them. So for somebody who's, who's exploring this as a, as a potential course of action, I mean, I know that there's, you can go like above the muscle, below the muscle. I don't know the specifics, but are there any, any, you know, ways to perform the surgery, the, to place the implant that are perhaps safer than others?
I think we got to go back to what you said. You said something important. You said they're partners and they enjoy having the implants less.
